Tirellizumab combined with carboplatin and albumin-paclitaxel neoadjuvant therapy+surgery

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Tirellizumab combined with carboplatin and albumin-paclitaxel neoadjuvant therapy+surgery
Treatment and conditionWhere it standsTrials
Tirellizumab combined with carboplatin and albumin-paclitaxel neoadjuvant therapy+surgery for squamous cell carcinoma of head and neckPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1